Predicting the Optimal Clinical Dosing Regimen for Promising COVID-19 Drugs

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 473885

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2022
  • Known Financial Commitments (USD)

    $4,709.17
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Nwabufo Chukwunonso K
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Manchester (England)
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A